Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Mary Eapen MBBS, DCh, MRCPI, MS

Mary Eapen MBBS, DCh, MRCPI, MS

Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Bone Marrow Transplant

Member of the Cancer Center


Leadership Positions

  • Associate Professor Population Health - Epidemiology
  • Publications

  • Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes. (Eapen M, Kurtzberg J, Zhang MJ, Hattersely G, Fei M, Mendizabal A, Chan KW, De Oliveira S, Schultz KR, Wall D, Horowitz MM, Wagner JE) Biol Blood Marrow Transplant 2017 Jul 03 PMID: 28684372 07/08/2017
  • Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. (Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O'Donnell PV, Perales MA, Raj K, Romee R, Rowley S, Rocha V, Salit RB, Solh M, Soiffer RJ, Fuchs EJ, Eapen M) J Clin Oncol 2017 Jun 23:JCO2017728428 PMID: 28644773 06/24/2017
  • Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. (Eapen M, Wang T, Veys PA, Boelens JJ, St Martin A, Spellman S, Bonfim CS, Brady C, Cant AJ, Dalle JH, Davies SM, Freeman J, Hsu KC, Fleischhauer K, Kenzey C, Kurtzberg J, Michel G, Orchard PJ, Paviglianiti A, Rocha V, Veneris MR, Volt F, Wynn R, Lee SJ, Horowitz MM, Gluckman E, Ruggeri A) Lancet Haematol 2017 Jul;4(7):e325-e333 PMID: 28623181 06/18/2017
  • HCT for SCID: one size does not fit all. (Eapen M) Blood 2017 May 25;129(21):2826-2827 PMID: 28546225 05/27/2017
  • Personalized Prognostic Risk Score for Long-Term Survival for Children with Acute Leukemia after Allogeneic Transplantation. (Bitan M, Ahn KW, Millard HR, Pulsipher MA, Abdel-Azim H, Auletta JJ, Brown V, Chan KW, Diaz MA, Dietz A, Vincent MG, Guilcher G, Hale GA, Hayashi RJ, Keating A, Mehta P, Myers K, Page K, Prestidge T, Shah NN, Smith AR, Woolfrey A, Thiel E, Davies SM, Eapen M) Biol Blood Marrow Transplant 2017 May 17 PMID: 28527984 05/22/2017
  • Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders. (Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K, Kalwak K, Kanazawa N, Karasu G, Kucuk ZY, Laberko A, Lange A, Mahlaoui N, Meisel R, Moshous D, Muramatsu H, Parikh S, Pasic S, Schmid I, Schuetz C, Schulz A, Schultz KR, Shaw PJ, Slatter MA, Sykora KW, Tamura S, Taskinen M, Wawer A, Wolska-Kus Nierz B, Cowan MJ, Fischer A, Gennery AR, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiencies, Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE), Center for International Blood and Marrow Transplant Research, Primary Immunodeficiency Treatment Consortium) J Allergy Clin Immunol 2017 Apr 07 PMID: 28392333 04/11/2017
  • Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia. (Kekre N, Zhang Y, Zhang MJ, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C, Deeg HJ, Kapoor N, Lee JW, Nakamura R, Pulsipher MA, Eapen M, Antin JH) Haematologica 2017 Jul;102(7):1291-1298 PMID: 28341733 03/28/2017
  • The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. (Brunstein C, Zhang MJ, Barker J, St Martin A, Bashey A, de Lima M, Dehn J, Hematti P, Perales MA, Rocha V, Territo M, Weisdorf D, Eapen M) Haematologica 2017 May;102(5):941-947 PMID: 28126967 PMCID: PMC5477613 01/28/2017
  • Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis. (Ustun C, Giannotti F, Zhang MJ, Wang HL, Brunstein C, Labopin M, Rocha V, de Lima M, Baron F, Sandmaier BM, Eapen M, Gluckman E, Nagler A, Weisdorf DJ, Ruggeri A) Leukemia 2017 Jun;31(6):1408-1414 PMID: 28119528 PMCID: PMC5462854 01/26/2017
  • Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission. (Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ, De Lima M, Saber W, Sandmaier B, Zhang MJ, Eapen M) Cancer 2017 Jun 01;123(11):2025-2034 PMID: 28117884 PMCID: PMC5445001 01/25/2017
  • Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. (Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M, Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research) Blood 2017 Mar 16;129(11):1548-1556 PMID: 27965196 PMCID: PMC5356458 12/15/2016
  • Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia. (Bonfim C, Ribeiro L, Nichele S, Loth G, Bitencourt M, Koliski A, Kuwahara C, Fabro AL, Pereira NF, Pilonetto D, Thakar M, Kiem HP, Page K, Fuchs EJ, Eapen M, Pasquini R) Biol Blood Marrow Transplant 2017 Feb;23(2):310-317 PMID: 27832981 11/12/2016
  • A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. (Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N) Blood 2016 Nov 24;128(21):2561-2567 PMID: 27625358 PMCID: PMC5123194 09/15/2016
  • Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. (O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers ME, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, Blaise D) Bone Marrow Transplant 2016 Dec;51(12):1599-1601 PMID: 27526284 PMCID: PMC5143194 08/16/2016
  • A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. (Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S) Bone Marrow Transplant 2017 Jan;52(1):59-65 PMID: 27427921 PMCID: PMC5215562 07/19/2016
  • Donor and recipient sex in allogeneic stem cell transplantation: what really matters. (Kim HT, Zhang MJ, Woolfrey AE, St Martin A, Chen J, Saber W, Perales MA, Armand P, Eapen M) Haematologica 2016 Oct;101(10):1260-1266 PMID: 27354023 PMCID: PMC5046656 06/30/2016
  • Changing Trends of Unrelated Umbilical Cord Blood Transplantation for Hematologic Diseases in Patients Older than Fifty Years: A Eurocord-Center for International Blood and Marrow Transplant Research Survey. (Rafii H, Ruggeri A, Volt F, Brunstein CG, Carreras J, Eapen M, Gluckman E, Weisdorf DJ) Biol Blood Marrow Transplant 2016 Sep;22(9):1717-20 PMID: 27220265 05/26/2016
  • Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. (Rocha V, Ruggeri A, Spellman S, Wang T, Sobecks R, Locatelli F, Askar M, Michel G, Arcese W, Iori AP, Purtill D, Danby R, Sanz GF, Gluckman E, Eapen M, Eurocord, Cord Blood Committee Cellular Therapy Immunobiology Working Party of the European Group for Blood and Marrow Transplantation, Netcord, and the Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2016 Jul;22(7):1284-9 PMID: 27090957 PMCID: PMC4915071 04/20/2016
  • Long-term Survival, Organ Function, and Malignancy after Hematopoietic Stem Cell Transplantation for Fanconi Anemia. (Bonfim C, Ribeiro L, Nichele S, Bitencourt M, Loth G, Koliski A, Funke VA, Pilonetto DV, Pereira NF, Flowers ME, Velleuer E, Dietrich R, Fasth A, Torres-Pereira CC, Pedruzzi P, Eapen M, Pasquini R) Biol Blood Marrow Transplant 2016 Jul;22(7):1257-63 PMID: 26976241 03/16/2016
  • Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study. (Anderlini P, Wu J, Gersten I, Ewell M, Tolar J, Antin JH, Adams R, Arai S, Eames G, Horwitz ME, McCarty J, Nakamura R, Pulsipher MA, Rowley S, Leifer E, Carter SL, DiFronzo NL, Horowitz MM, Confer D, Deeg HJ, Eapen M) Lancet Haematol 2015 Sep;2(9):e367-75 PMID: 26685770 PMCID: PMC4861234 12/22/2015
  • The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. (Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales MA, Setterholm M, Woolfrey AE, Yu N, Eapen M) Blood 2016 Jan 14;127(2):260-7 PMID: 26527675 PMCID: PMC4713163 11/04/2015
  • Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation. (Pagliuca S, Gérard L, Kulasekararaj A, Eapen M, Boutboul D, Martin H, Salvino MA, Knol-Bout C, Dufour C, Peffault de Latour R, Marsh J) Bone Marrow Transplant 2016 Feb;51(2):313-5 PMID: 26479981 10/20/2015
  • In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children. (Ponce DM, Eapen M, Sparapani R, O'Brien TA, Chan KW, Chen J, Craddock J, Schultz KR, Wagner JE, Perales MA, Barker JN) Biol Blood Marrow Transplant 2015 Dec;21(12):2173-9 PMID: 26327630 PMCID: PMC4639413 09/04/2015
  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. (Ciurea SO, Zhang MJ, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, Armand P, Antin JH, Chen J, Devine SM, Fowler DH, Luznik L, Nakamura R, O'Donnell PV, Perales MA, Pingali SR, Porter DL, Riches MR, Ringdén OT, Rocha V, Vij R, Weisdorf DJ, Champlin RE, Horowitz MM, Fuchs EJ, Eapen M) Blood 2015 Aug 20;126(8):1033-40 PMID: 26130705 PMCID: PMC4543223 07/02/2015
  • Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure. (Ayas M, Eapen M, Le-Rademacher J, Carreras J, Abdel-Azim H, Alter BP, Anderlini P, Battiwalla M, Bierings M, Buchbinder DK, Bonfim C, Camitta BM, Fasth AL, Gale RP, Lee MA, Lund TC, Myers KC, Olsson RF, Page KM, Prestidge TD, Radhi M, Shah AJ, Schultz KR, Wirk B, Wagner JE, Deeg HJ) Biol Blood Marrow Transplant 2015 Oct;21(10):1790-5 PMID: 26116087 PMCID: PMC4568139 06/28/2015
  • Who is the best alternative allotransplant donor? (Gale RP, Eapen M) Bone Marrow Transplant 2015 Jun;50 Suppl 2:S40-2 PMID: 26039206 PMCID: PMC4520408 06/04/2015
  • Hematopoietic stem cell transplantation for infantile osteopetrosis. (Orchard PJ, Fasth AL, Le Rademacher J, He W, Boelens JJ, Horwitz EM, Al-Seraihy A, Ayas M, Bonfim CM, Boulad F, Lund T, Buchbinder DK, Kapoor N, O'Brien TA, Perez MA, Veys PA, Eapen M) Blood 2015 Jul 09;126(2):270-6 PMID: 26012570 PMCID: PMC4497967 05/28/2015
  • Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia. (Mehta PA, Zhang MJ, Eapen M, He W, Seber A, Gibson B, Camitta BM, Kitko CL, Dvorak CC, Nemecek ER, Frangoul HA, Abdel-Azim H, Kasow KA, Lehmann L, Gonzalez Vicent M, Diaz Pérez MA, Ayas M, Qayed M, Carpenter PA, Jodele S, Lund TC, Leung WH, Davies SM) Biol Blood Marrow Transplant 2015 Jul;21(7):1273-7 PMID: 25865650 PMCID: PMC4465998 04/14/2015
  • Hematopoietic cell transplantation for acute leukemia: selecting donors. (Eapen M) Haematologica 2015 Apr;100(4):414-5 PMID: 25828086 PMCID: PMC4380712 04/02/2015
  • Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning. (Veys PA, Nanduri V, Baker KS, He W, Bandini G, Biondi A, Dalissier A, Davis JH, Eames GM, Egeler RM, Filipovich AH, Fischer A, Jürgens H, Krance R, Lanino E, Leung WH, Matthes S, Michel G, Orchard PJ, Pieczonka A, Ringdén O, Schlegel PG, Sirvent A, Vettenranta K, Eapen M) Br J Haematol 2015 Jun;169(5):711-8 PMID: 25817915 PMCID: PMC4433436 03/31/2015
  • One-unit versus two-unit cord-blood transplantation. (Wagner JE Jr, Eapen M, Kurtzberg J) N Engl J Med 2015 Jan 15;372(3):288 PMID: 25587953 01/15/2015
  • Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. (Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M) Biol Blood Marrow Transplant 2015 Apr;21(4):688-95 PMID: 25543094 PMCID: PMC4359657 12/30/2014
  • Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. (Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Champlin RE) J Clin Oncol 2015 Feb 01;33(4):364-9 PMID: 25534391 PMCID: PMC4302216 12/24/2014
  • Unrelated donor transplantation: peripheral blood or bone marrow--does it matter? (Eapen M) Best Pract Res Clin Haematol 2014 Sep-Dec;27(3-4):278-82 PMID: 25455278 12/03/2014
  • One-unit versus two-unit cord-blood transplantation for hematologic cancers. (Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2014 Oct 30;371(18):1685-94 PMID: 25354103 PMCID: PMC4257059 10/30/2014
  • Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy. (Eapen M, Logan BR, Appelbaum FR, Antin JH, Anasetti C, Couriel DR, Chen J, Maziarz RT, McCarthy PL, Nakamura R, Ratanatharathorn V, Vij R, Champlin RE) Biol Blood Marrow Transplant 2015 Jan;21(1):55-9 PMID: 25255165 PMCID: PMC4272909 09/26/2014
  • Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. (Kim SY, Le Rademacher J, Antin JH, Anderlini P, Ayas M, Battiwalla M, Carreras J, Kurtzberg J, Nakamura R, Eapen M, Deeg HJ) Haematologica 2014 Dec;99(12):1868-75 PMID: 25107891 PMCID: PMC4258748 08/12/2014
  • HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. (Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M) N Engl J Med 2014 Jul 24;371(4):339-48 PMID: 25054717 07/24/2014
  • Outcomes after hematopoietic stem cell transplantation for children with I-cell disease. (Lund TC, Cathey SS, Miller WP, Eapen M, Andreansky M, Dvorak CC, Davis JH, Dalal JD, Devine SM, Eames GM, Ferguson WS, Giller RH, He W, Kurtzberg J, Krance R, Katsanis E, Lewis VA, Sahdev I, Orchard PJ) Biol Blood Marrow Transplant 2014 Nov;20(11):1847-51 PMID: 25016194 PMCID: PMC4194244 07/13/2014
  • Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. (Ruggeri A, Labopin M, Sormani MP, Sanz G, Sanz J, Volt F, Michel G, Locatelli F, Diaz De Heredia C, O'Brien T, Arcese W, Iori AP, Querol S, Kogler G, Lecchi L, Pouthier F, Garnier F, Navarrete C, Baudoux E, Fernandes J, Kenzey C, Eapen M, Gluckman E, Rocha V, Saccardi R, Eurocord, Cord Blood Committee EBMT, Netcord) Haematologica 2014 Sep;99(9):1509-15 PMID: 24972767 PMCID: PMC4562541 06/29/2014
  • Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome. (Törlén J, Ringdén O, Le Rademacher J, Batiwalla M, Chen J, Erkers T, Ho V, Kebriaei P, Keever-Taylor C, Kindwall-Keller T, Lazarus HM, Laughlin MJ, Lill M, O'Brien T, Perales MA, Rocha V, Savani BN, Szwajcer D, Valcarcel D, Eapen M) Biol Blood Marrow Transplant 2014 Sep;20(9):1418-25 PMID: 24892261 PMCID: PMC4127369 06/04/2014
  • Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies. (Eapen M, O'Donnell P, Brunstein CG, Wu J, Barowski K, Mendizabal A, Fuchs EJ) Biol Blood Marrow Transplant 2014 Oct;20(10):1485-92 PMID: 24862638 PMCID: PMC4163123 05/28/2014
  • Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer. (Roth JA, Bensink ME, O'Donnell PV, Fuchs EJ, Eapen M, Ramsey SD) J Comp Eff Res 2014 Mar;3(2):135-44 PMID: 24645687 PMCID: PMC4036637 03/22/2014
  • Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis. (Weisdorf D, Eapen M, Ruggeri A, Zhang MJ, Zhong X, Brunstein C, Ustun C, Rocha V, Gluckman E) Biol Blood Marrow Transplant 2014 Jun;20(6):816-22 PMID: 24582782 PMCID: PMC4085692 03/04/2014
  • Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. (Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR), and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)) Biol Blood Marrow Transplant 2014 May;20(5):662-7 PMID: 24525277 PMCID: PMC4071962 02/15/2014
  • Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. (Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA, CIBMTR Pediatric Cancer Working Committee) Pediatr Blood Cancer 2014 Jun;61(6):1126-8 PMID: 24391118 PMCID: PMC4080799 01/07/2014
  • Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. (Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR) Biol Blood Marrow Transplant 2014 Feb;20(2):202-8 PMID: 24184335 PMCID: PMC3924751 11/05/2013
  • Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. (Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V, Center for International Blood and Marrow Transplant Research, Netcord, Eurocord, and the European Group for Blood and Marrow Transplantation) Blood 2014 Jan 02;123(1):133-40 PMID: 24141369 PMCID: PMC3879902 10/22/2013
  • Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. (Eckrich MJ, Ahn KW, Champlin RE, Coccia P, Godder K, Horan J, Margolis D, Deeg HJ, Eapen M) Am J Hematol 2014 Feb;89(2):125-9 PMID: 24122901 PMCID: PMC4109804 10/15/2013
  • Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. (Marks DI, Woo KA, Zhong X, Appelbaum FR, Bachanova V, Barker JN, Brunstein CG, Gibson J, Kebriaei P, Lazarus HM, Olsson R, Perales MA, Pidala J, Savani B, Rocha V, Eapen M) Haematologica 2014 Feb;99(2):322-8 PMID: 24056817 PMCID: PMC3912963 09/24/2013
  • Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. (Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG) Pediatr Blood Cancer 2014 Feb;61(2):269-75 PMID: 23955900 PMCID: PMC3919967 08/21/2013
  • Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study. (Locatelli F, Crotta A, Ruggeri A, Eapen M, Wagner JE, Macmillan ML, Zecca M, Kurtzberg J, Bonfim C, Vora A, Díaz de Heredia C, Teague L, Stein J, O'Brien TA, Bittencourt H, Madureira A, Strahm B, Peters C, Niemeyer C, Gluckman E, Rocha V) Blood 2013 Sep 19;122(12):2135-41 PMID: 23926304 PMCID: PMC3836039 08/09/2013
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. (Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA) Biol Blood Marrow Transplant 2013 Aug;19(8):1238-43 PMID: 23751955 PMCID: PMC3736557 06/12/2013
  • Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. (Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, Wraith E, Cavazzana-Calvo M, Rovelli A, Fischer A, Tolar J, Prasad VK, Escolar M, Gluckman E, O'Meara A, Orchard PJ, Veys P, Eapen M, Kurtzberg J, Rocha V, Eurocord, Inborn Errors Working Party of European Blood and Marrow Transplant group, Duke University Blood and Marrow Transplantation Program, Centre for International Blood and Marrow Research) Blood 2013 May 09;121(19):3981-7 PMID: 23493783 PMCID: PMC3836041 03/16/2013
  • Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. (Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA, CIBMTR Pediatric Cancer Working Committee) Biol Blood Marrow Transplant 2013 Jun;19(6):893-7 PMID: 23467128 PMCID: PMC3707801 03/08/2013
  • Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? (Alousi AM, Le-Rademacher J, Saliba RM, Appelbaum FR, Artz A, Benjamin J, Devine SM, Kan F, Laughlin MJ, Lazarus HM, Liesveld J, Perales MA, Maziarz RT, Sabloff M, Waller EK, Eapen M, Champlin RE) Blood 2013 Mar 28;121(13):2567-73 PMID: 23361908 PMCID: PMC3612864 01/31/2013
  • Cord-blood engraftment with ex vivo mesenchymal-cell coculture. (de Lima M, McNiece I, Robinson SN, Munsell M, Eapen M, Horowitz M, Alousi A, Saliba R, McMannis JD, Kaur I, Kebriaei P, Parmar S, Popat U, Hosing C, Champlin R, Bollard C, Molldrem JJ, Jones RB, Nieto Y, Andersson BS, Shah N, Oran B, Cooper LJ, Worth L, Qazilbash MH, Korbling M, Rondon G, Ciurea S, Bosque D, Maewal I, Simmons PJ, Shpall EJ) N Engl J Med 2012 Dec 13;367(24):2305-15 PMID: 23234514 PMCID: PMC3805360 12/14/2012
  • Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. (Scaradavou A, Brunstein CG, Eapen M, Le-Rademacher J, Barker JN, Chao N, Cutler C, Delaney C, Kan F, Isola L, Karanes C, Laughlin MJ, Wagner JE, Shpall EJ) Blood 2013 Jan 31;121(5):752-8 PMID: 23223509 PMCID: PMC3563363 12/12/2012
  • HCT for nonmalignant disorders. (Tisdale JF, Eapen M, Saccardi R) Biol Blood Marrow Transplant 2013 Jan;19(1 Suppl):S6-9 PMID: 23104188 10/30/2012
  • Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia. (Tracey J, Zhang MJ, Thiel E, Sobocinski KA, Eapen M) Biol Blood Marrow Transplant 2013 Feb;19(2):255-9 PMID: 23041605 PMCID: PMC3553255 10/09/2012
  • Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. (Horan J, Wang T, Haagenson M, Spellman SR, Dehn J, Eapen M, Frangoul H, Gupta V, Hale GA, Hurley CK, Marino S, Oudshoorn M, Reddy V, Shaw P, Lee SJ, Woolfrey A) Blood 2012 Oct 04;120(14):2918-24 PMID: 22829628 PMCID: PMC3466972 07/26/2012
  • Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. (Rocha V, Spellman S, Zhang MJ, Ruggeri A, Purtill D, Brady C, Baxter-Lowe LA, Baudoux E, Bergamaschi P, Chow R, Freed B, Koegler G, Kurtzberg J, Larghero J, Lecchi L, Nagler A, Navarrette C, Prasad V, Pouthier F, Price T, Ratanatharathorn V, van Rood JJ, Horowitz MM, Gluckman E, Eapen M, Eurocord-European Blood and Marrow Transplant Group and the Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2012 Dec;18(12):1890-6 PMID: 22814031 PMCID: PMC3826155 07/21/2012
  • Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. (Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M) Biol Blood Marrow Transplant 2012 Nov;18(11):1727-33 PMID: 22766220 PMCID: PMC3472079 07/07/2012
  • A perspective on the selection of unrelated donors and cord blood units for transplantation. (Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK, National Marrow Donor Program, Center for International Blood and Marrow Transplant Research) Blood 2012 Jul 12;120(2):259-65 PMID: 22596257 PMCID: PMC3398760 05/19/2012
  • Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia. (Veys P, Wynn RF, Ahn KW, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC, Duerst RE, Gross TG, Kapoor N, Kitko C, Krance RA, Leung W, Lewis VA, Steward C, Wagner JE, Carpenter PA, Eapen M) Blood 2012 Jun 21;119(25):6155-61 PMID: 22573402 PMCID: PMC3383023 05/11/2012
  • Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. (Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID, Carter SL, Horowitz MM, Nakamura R, Pulsipher MA, Difronzo NL, Confer DL, Eapen M, Anderlini P) Biol Blood Marrow Transplant 2012 Jul;18(7):1007-11 PMID: 22546497 PMCID: PMC3677744 05/02/2012
  • Allogeneic transplantation for aplastic anemia. (Eapen M) Hematology 2012 Apr;17 Suppl 1:S15-7 PMID: 22507769 04/25/2012
  • Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. (Brunstein CG, Eapen M, Ahn KW, Appelbaum FR, Ballen KK, Champlin RE, Cutler C, Kan F, Laughlin MJ, Soiffer RJ, Weisdorf DJ, Woolfrey A, Wagner JE) Blood 2012 Jun 07;119(23):5591-8 PMID: 22496153 PMCID: PMC3369691 04/13/2012
  • Peripheral blood or marrow: is one better than the other? (Eapen M) Biol Blood Marrow Transplant 2012 Jun;18(6):819 PMID: 22449609 03/28/2012
  • Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. (Eapen M, Ahn KW, Orchard PJ, Cowan MJ, Davies SM, Fasth A, Hassebroek A, Ayas M, Bonfim C, O'Brien TA, Gross TG, Horwitz M, Horwitz E, Kapoor N, Kurtzberg J, Majhail N, Ringden O, Szabolcs P, Veys P, Baker KS) Biol Blood Marrow Transplant 2012 Sep;18(9):1438-45 PMID: 22430083 PMCID: PMC3390445 03/21/2012
  • Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. (Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL) Biol Blood Marrow Transplant 2012 Aug;18(8):1204-10 PMID: 22406037 PMCID: PMC3890239 03/13/2012
  • HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival. (Battiwalla M, Wang T, Carreras J, Deeg HJ, Ayas M, Bajwa RP, George B, Gupta V, Pasquini R, Schrezenmeier H, Passweg JR, Schultz KR, Eapen M) Biol Blood Marrow Transplant 2012 Sep;18(9):1401-6 PMID: 22387349 PMCID: PMC3406237 03/06/2012
  • Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S) Biol Blood Marrow Transplant 2012 Aug;18(8):1265-72 PMID: 22343376 PMCID: PMC3618440 02/22/2012
  • Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. (Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, Brown M, Champlin RE, Garcia-Lopez J, Hattersely G, Koegler G, Laughlin MJ, Michel G, Nabhan SK, Smith FO, Horowitz MM, Gluckman E, Rocha V, Eurocord-European Group for Blood and Marrow Transplantation, Netcord, Center for International Blood and Marrow Transplant Research) Lancet Oncol 2011 Dec;12(13):1214-21 PMID: 21982422 PMCID: PMC3245836 10/11/2011
  • Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. (Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A, Eapen M) Biol Blood Marrow Transplant 2011 Dec;17(12):1869-73 PMID: 21771571 PMCID: PMC3217167 07/21/2011
  • Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission. (Nemecek ER, Ellis K, He W, Bunin NJ, Bajwa RS, Cheerva A, Cairo MS, Dvorak C, Duval M, Davies S, Eapen M, Gross TG, Hussein AA, MacMillan ML, Mehta PA, Pulsipher MA, Seber A, Woolfrey AE, Frangoul HA, Carpenter PA) Biol Blood Marrow Transplant 2011 Dec;17(12):1833-40 PMID: 21683798 PMCID: PMC3372321 06/21/2011
  • Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. (Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JC, Deeg HJ) Blood 2011 Sep 01;118(9):2618-21 PMID: 21677312 PMCID: PMC3167362 06/17/2011
  • Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research. (Kamani NR, Kumar S, Hassebroek A, Eapen M, LeRademacher J, Casper J, Cowan M, Sánchez de Toledo J, Ferster A, Szabolcs P, Wingard JR, Horwitz E, Filipovich AH) Biol Blood Marrow Transplant 2011 Dec;17(12):1783-9 PMID: 21658461 PMCID: PMC3370408 06/11/2011
  • Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. (Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, Devine SM, Wingard JR, Aljitawi OS, Cutler CS, Jagasia MH, Ballen KK, Eapen M, O'Donnell PV, Blood and Marrow Transplant Clinical Trials Network) Blood 2011 Jul 14;118(2):282-8 PMID: 21527516 PMCID: PMC3138683 04/30/2011
  • Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. (Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M) Blood 2011 Jun 23;117(25):6963-70 PMID: 21464372 PMCID: PMC3128486 04/06/2011
  • Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. (Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Fasth A, Lo Nigro L, Ayas M, Purtill D, Boudjedir K, Chaves W, Walters MC, Wagner J, Gluckman E, Rocha V, Eurocord Registry, Center for International Blood and Marrow Transplant Research, New York Blood Center) Biol Blood Marrow Transplant 2011 Sep;17(9):1375-82 PMID: 21277376 PMCID: PMC3395002 02/01/2011
  • Alternative donor transplantation for aplastic anemia. (Eapen M, Horowitz MM) Hematology Am Soc Hematol Educ Program 2010;2010:43-6 PMID: 21239769 01/18/2011
  • Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. (Madureira AB, Eapen M, Locatelli F, Teira P, Zhang MJ, Davies SM, Picardi A, Woolfrey A, Chan KW, Socié G, Vora A, Bertrand Y, Sales-Bonfim CM, Gluckman E, Niemeyer C, Rocha V, Eurocord-European Blood and Marrow Transplant Group, Center of International Blood and Marrow Transplant Registry, European Working Group on childhood MDS) Leukemia 2011 Mar;25(3):449-54 PMID: 21135856 PMCID: PMC3365546 12/08/2010
  • HLA-matched sibling bone marrow transplantation for β-thalassemia major. (Sabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li CK, Irfan SM, Bredeson CN, Cowan MJ, Gale RP, Hale GA, Horan J, Hongeng S, Eapen M, Walters MC) Blood 2011 Feb 03;117(5):1745-50 PMID: 21119108 PMCID: PMC3056598 12/02/2010
  • Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. (Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, Isola L, Ispizua AU, Lazarus H, Marsh J, Russell J, Sabloff M, Waller EK, Eapen M) Biol Blood Marrow Transplant 2011 Jul;17(7):1018-24 PMID: 21034842 PMCID: PMC3114180 11/03/2010
  • Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. (Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH) Biol Blood Marrow Transplant 2011 Mar;17(3):291-9 PMID: 21034841 PMCID: PMC3053041 11/03/2010
  • Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors. (Gupta V, Eapen M, Brazauskas R, Carreras J, Aljurf M, Gale RP, Hale GA, Ilhan O, Passweg JR, Ringdén O, Sabloff M, Schrezenmeier H, Socié G, Marsh JC) Haematologica 2010 Dec;95(12):2119-25 PMID: 20851870 PMCID: PMC2995571 09/21/2010
  • Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children. (Woodard P, Carpenter PA, Davies SM, Gross TG, He W, Zhang MJ, Horn BN, Margolis DA, Perentesis JP, Sanders JE, Schultz KR, Seber A, Woods WG, Eapen M) Biol Blood Marrow Transplant 2011 May;17(5):723-8 PMID: 20813197 PMCID: PMC3033968 09/04/2010
  • Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. (Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE, Center for International Blood and Marrow Transplant Research, Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation), National Cord Blood Program of the New York Blood Center) Lancet Oncol 2010 Jul;11(7):653-60 PMID: 20558104 PMCID: PMC3163510 06/19/2010
  • Bone marrow or peripheral blood. (Eapen M) Biol Blood Marrow Transplant 2010 Jun;16(6):868-9 PMID: 20451848 05/11/2010
  • Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. (Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS) Bone Marrow Transplant 2011 Jan;46(1):70-6 PMID: 20436518 PMCID: PMC3366187 05/04/2010
  • Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia. (Verneris MR, Eapen M, Duerst R, Carpenter PA, Burke MJ, Afanasyev BV, Cowan MJ, He W, Krance R, Li CK, Tan PL, Wagner JE, Davies SM) Biol Blood Marrow Transplant 2010 Sep;16(9):1237-44 PMID: 20302960 PMCID: PMC2904410 03/23/2010
  • Transplant outcomes in acute leukemia. I. (Eapen M, Wagner JE) Semin Hematol 2010 Jan;47(1):46-50 PMID: 20109611 PMCID: PMC2814074 01/30/2010
  • Acid sphingomyelinase deficiency does not protect from graft-versus-host disease in transplant recipients with Niemann-Pick disease. (Tolar J, Eapen M, Orchard PJ, Blazar BR) Blood 2010 Jan 14;115(2):434-5 PMID: 20075175 01/16/2010
  • The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. (Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ) Biol Blood Marrow Transplant 2010 Feb;16(2):253-62 PMID: 19822219 PMCID: PMC2952392 10/14/2009
  • Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. (Gross TG, Hale GA, He W, Camitta BM, Sanders JE, Cairo MS, Hayashi RJ, Termuhlen AM, Zhang MJ, Davies SM, Eapen M) Biol Blood Marrow Transplant 2010 Feb;16(2):223-30 PMID: 19800015 PMCID: PMC2911354 10/06/2009
  • Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. (Lazarus HM, Kan F, Tarima S, Champlin RE, Confer DL, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M) Biol Blood Marrow Transplant 2009 May;15(5):589-96 PMID: 19361751 PMCID: PMC2688780 04/14/2009
  • Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia. (Horan JT, Carreras J, Tarima S, Camitta BM, Gale RP, Hale GA, Hinterberger W, Marsh J, Passweg JR, Walters MC, Eapen M) Biol Blood Marrow Transplant 2009 May;15(5):626-31 PMID: 19361755 PMCID: PMC2692140 04/14/2009
  • Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. (Qasim W, Cavazzana-Calvo M, Davies EG, Davis J, Duval M, Eames G, Farinha N, Filopovich A, Fischer A, Friedrich W, Gennery A, Heilmann C, Landais P, Horwitz M, Porta F, Sedlacek P, Seger R, Slatter M, Teague L, Eapen M, Veys P) Pediatrics 2009 Mar;123(3):836-40 PMID: 19255011 PMCID: PMC3380632 03/04/2009
  • Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. (Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S) Pediatrics 2009 Mar;123(3):1011-7 PMID: 19255033 PMCID: PMC3120215 03/04/2009
  • Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? (Gale RP, Eapen M, Logan B, Zhang MJ, Lazarus HM) Bone Marrow Transplant 2009 Mar;43(6):435-46 PMID: 19182830 02/03/2009
  • Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. (Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, Buckley RH, Eapen M, Kamani NR, O'Reilly RJ, Parkman R, Roifman CM, Sullivan KE, Filipovich AH, Fleisher TA, Shearer WT) J Allergy Clin Immunol 2008 Dec;122(6):1087-96 PMID: 18992926 PMCID: PMC3357108 11/11/2008
  • Variation in supportive care practices in hematopoietic cell transplantation. (Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, Jagasia M, Kernan NA, Loberiza FR Jr, Bevans M, Soiffer RJ, Joffe S) Biol Blood Marrow Transplant 2008 Nov;14(11):1231-8 PMID: 18940677 PMCID: PMC3304538 10/23/2008
  • HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. (Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang MJ, Eapen M, Wagner JE) Biol Blood Marrow Transplant 2008 Oct;14(10):1141-7 PMID: 18804044 PMCID: PMC2581414 09/23/2008
  • Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. (Bunin NJ, Davies SM, Aplenc R, Camitta BM, DeSantes KB, Goyal RK, Kapoor N, Kernan NA, Rosenthal J, Smith FO, Eapen M) J Clin Oncol 2008 Sep 10;26(26):4326-32 PMID: 18779619 PMCID: PMC2653120 09/10/2008
  • Principles and analysis of hematopoietic stem cell transplantation outcomes: the physician's perspective. (Eapen M, Rocha V) Lifetime Data Anal 2008 Dec;14(4):379-88 PMID: 18607725 07/09/2008
  • Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. (McCullough J, Kahn J, Adamson J, Anderlini P, Benjamin R, Confer D, Eapen M, Hirsch B, Kuter D, Lazarus E, Pamphilon D, Stroncek D, Sugarman J, Wilson R) Transfusion 2008 Sep;48(9):2008-25 PMID: 18564401 06/20/2008
  • Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. (Baker KS, Filipovich AH, Gross TG, Grossman WJ, Hale GA, Hayashi RJ, Kamani NR, Kurian S, Kapoor N, Ringdén O, Eapen M) Bone Marrow Transplant 2008 Aug;42(3):175-80 PMID: 18454181 05/06/2008
  • Individual physician practice variation in hematopoietic cell transplantation. (Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR Jr, Soiffer RJ, Eapen M) J Clin Oncol 2008 May 01;26(13):2162-70 PMID: 18378566 04/02/2008
  • Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. (Perez-Albuerne ED, Eapen M, Klein J, Gross TJ, Lipton JM, Baker KS, Woolfrey A, Kamani N) Br J Haematol 2008 Apr;141(2):216-23 PMID: 18307564 PMCID: PMC3164958 03/01/2008
  • Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. (Gardner SL, Carreras J, Boudreau C, Camitta BM, Adams RH, Chen AR, Davies SM, Edwards JR, Grovas AC, Hale GA, Lazarus HM, Arora M, Stiff PJ, Eapen M) Bone Marrow Transplant 2008 May;41(10):867-72 PMID: 18246113 PMCID: PMC3164955 02/05/2008
  • State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. (Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL, National Marrow Donor Program) Biol Blood Marrow Transplant 2008 Jan;14(1):1-6 PMID: 18158954 12/27/2007
  • Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Zhang MJ, Devidas M, Raetz E, Barredo JC, Ritchey AK, Godder K, Grupp S, Lewis VA, Malloy K, Carroll WL, Davies SM, Camitta BM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Leukemia 2008 Feb;22(2):281-6 PMID: 18033318 11/23/2007
  • Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. (Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C) Biol Blood Marrow Transplant 2007 Dec;13(12):1461-8 PMID: 18022576 PMCID: PMC2267869 11/21/2007
  • High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. (Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, Weisdorf D, Williams TM, Anasetti C) Blood 2007 Dec 15;110(13):4576-83 PMID: 17785583 09/06/2007
  • Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. (Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE) Lancet 2007 Jun 09;369(9577):1947-54 PMID: 17560447 06/15/2007
  • Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. (Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AV, Socie G, Eapen M) Blood 2007 Aug 15;110(4):1397-400 PMID: 17475907 PMCID: PMC1939910 05/04/2007
  • Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. (Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA, Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A, Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research) Br J Haematol 2007 Jun;137(5):479-85 PMID: 17459050 04/27/2007
  • Interleukin-1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia. (Mehta PA, Eapen M, Klein JP, Gandham S, Elliott J, Zamzow T, Combs M, Aplenc R, MacMillan ML, Weisdorf DJ, Petersdorf E, Davies SM) Br J Haematol 2007 Apr;137(2):152-7 PMID: 17391495 PMCID: PMC2914502 03/30/2007
  • Hematopoietic cell transplantation for Chediak-Higashi syndrome. (Eapen M, DeLaat CA, Baker KS, Cairo MS, Cowan MJ, Kurtzberg J, Steward CG, Veys PA, Filipovich AH) Bone Marrow Transplant 2007 Apr;39(7):411-5 PMID: 17293882 02/13/2007
  • Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. (Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, Bredeson CN, Eapen M, Horowitz MM) Blood 2007 May 15;109(10):4582-5 PMID: 17272503 PMCID: PMC1885491 02/03/2007
  • HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. (Wade JA, Hurley CK, Takemoto SK, Thompson J, Davies SM, Fuller TC, Rodey G, Confer DL, Noreen H, Haagenson M, Kan F, Klein J, Eapen M, Spellman S, Kollman C) Blood 2007 May 01;109(9):4064-70 PMID: 17202313 PMCID: PMC1874562 01/05/2007
  • Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. (Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD) Blood 2007 Mar 01;109(5):2256-62 PMID: 17038525 PMCID: PMC1801062 10/14/2006
  • Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. (Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE, International Bone Marrow Transplant Registry, European Group for Blood and Marrow Transplantation) Blood 2006 Dec 15;108(13):4288-90 PMID: 16946302 PMCID: PMC1895450 09/02/2006
  • The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. (Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Weisdorf D, Davies SM, KIR Study Group, Center for International Blood and Marrow Transplantation Research) Biol Blood Marrow Transplant 2006 Aug;12(8):876-84 PMID: 16864058 07/26/2006
  • Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Blood 2006 Jun 15;107(12):4961-7 PMID: 16493003 PMCID: PMC1895819 02/24/2006
  • Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. (Passweg JR, Pérez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh JC, Pasquini R, Schrezenmeier H, Socié G, Zhang MJ, Bredeson C) Bone Marrow Transplant 2006 Apr;37(7):641-9 PMID: 16489361 02/21/2006
  • Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. (Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE) J Clin Oncol 2006 Jan 01;24(1):145-51 PMID: 16382124 12/31/2005
  • Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities. (Schwake CJ, Eapen M, Lee SJ, Freytes CO, Giralt SA, Navarro WH, Rizzo JD, van Besien K, Loberiza FR Jr) Biol Blood Marrow Transplant 2005 Dec;11(12):988-98 PMID: 16338621 12/13/2005
  • Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. (Talano JM, Casper JT, Camitta BM, Keever-Taylor CA, Murray KJ, Eapen M, Pierce KL, Margolis DA) Bone Marrow Transplant 2006 Jan;37(2):135-41 PMID: 16273115 11/08/2005
  • Bone marrow transplantation for diamond-blackfan anemia. (Roy V, Pérez WS, Eapen M, Marsh JC, Pasquini M, Pasquini R, Mustafa MM, Bredeson CN, Non-Malignant Marrow Disorders Working Committee of the International Bone Marrow Transplant Registry) Biol Blood Marrow Transplant 2005 Aug;11(8):600-8 PMID: 16041310 07/26/2005
  • Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. (Loberiza FR Jr, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD) Blood 2005 Apr 01;105(7):2979-87 PMID: 15598815 12/16/2004
  • Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. (Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM) N Engl J Med 2004 Nov 25;351(22):2265-75 PMID: 15564543 11/27/2004
  • Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. (Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR Jr, Ringdén O, Wagner JE) J Clin Oncol 2004 Dec 15;22(24):4872-80 PMID: 15520055 11/03/2004
  • Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. (Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH Jr, Sandler ES, Yeager AM, Edwards JR, Horowitz MM) J Clin Oncol 2004 Sep 15;22(18):3798-804 PMID: 15365077 09/15/2004
  • Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. (Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M) Bone Marrow Transplant 2004 Oct;34(8):721-7 PMID: 15322568 08/24/2004
  • Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. (Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr) J Clin Oncol 2003 Oct 15;21(20):3754-60 PMID: 14551294 10/11/2003
  • Bullous acral erythema secondary to high-dose methotrexate. (Morrell DS, Challgren E, Eapen M, Esterly NB) J Pediatr Hematol Oncol 2002 Mar-Apr;24(3):240 PMID: 11990316 05/07/2002
  • Late outcomes after bone marrow transplant for aplastic anaemia. (Eapen M, Ramsay NK, Mertens AC, Robison LL, DeFor T, Davies SM) Br J Haematol 2000 Dec;111(3):754-60 PMID: 11122134 12/21/2000
  • Massive splenomegaly and Epstein-Barr virus-associated infectious mononucleosis in a patient with Gaucher disease. (Eapen M, Hostetter M, Neglia JP) J Pediatr Hematol Oncol 1999 Jan-Feb;21(1):47-9 PMID: 10029812 02/25/1999
  • Late graft rejection and second infusion of bone marrow in children with aplastic anaemia. (Eapen M, Davies SM, Ramsay NK) Br J Haematol 1999 Jan;104(1):186-8 PMID: 10027732 02/23/1999
  • Hematopoietic stem cell transplantation for infantile osteopetrosis. (Eapen M, Davies SM, Ramsay NK, Orchard PJ) Bone Marrow Transplant 1998 Nov;22(10):941-6 PMID: 9849690 12/16/1998
  • Last update: 07/27/2017
    jenkins-FCD Prod-122 cd2d52783a48a4ccec26c8f4da41e571848a97a0